SCHULHOFF & CO INC

Position in FATE — Fate Therapeutics Inc

CIK 1080197 CINCINNATI, OH

Position in FATE

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$120,000

New position

Shares Held

100,000

first reported quarter

Ownership

0.086%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

SCHULHOFF & CO INC holds $2,775,219 across 3 Biotechnology names. FATE ranks #3 (4.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CTMX	CytomX Therapeutics, Inc.	477,550	$2,244,485
2	SPRY	ARS Pharmaceuticals, Inc.	51,150	$410,734
3	FATE	Fate Therapeutics Inc This page	100,000	$120,000

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$120,000	100,000	—	Shares	Sole	2026-05-11
No filing history on record for this holder in this stock.